Searched for
MANKIND PHARMA Q1 UPDATE
Macros, AI, geopolitical overhang to drag Q1 showing of IT cos: Motilal OswalIndian IT firms are bracing for a subdued first quarter of FY27, with global economic headwinds, AI's impact, and geopolitical tensions dam...- Explained: Why Tata Elxsi shares crashed 7% after KPIT Tech’s Q1 revenue, profit guidance warningTata Elxsi shares fell sharply on Wednesday after rival KPIT Technologies warned of weaker-than-expected Q1FY27 revenue and margins due to ...
- KPIT Tech shares hit by downgrades, target price cuts. What JPMorgan and other brokerages saidKPIT Technologies shares plunged after the company issued a weak preliminary Q1 FY27 business update, prompting several brokerages, includi...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- KPIT Tech shares sink 17%, see worst plunge since 2020 Covid crash. Time to buy or more pain ahead?KPIT Technologies shares dropped to a fresh 52-week low on Wednesday after the company warned of weaker-than-expected Q1 FY27 revenue and m...
- Rahul Jain sees challenging FY27 for KPIT despite strong deal pipelineKPIT Technologies faces near-term growth concerns due to project setbacks, impacting its FY27 outlook. Analysts anticipate a challenging Q1...
- Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
- KPIT Tech shares crash 17% as company expects Q1 revenue decline, sharp hit to marginsKPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...
- Ola Electric doubles QoQ growth in Q1 FY26; June vehicle registrations at 16,144 unitsOla Electric witnessed a significant surge in electric two-wheeler registrations during the April-June quarter, nearly doubling from the pr...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities declined for a second session as investors stayed cautious despite easing geopolitical tensions. Sensex lost nearly 250 poi...
- Oyo IPO: How real is Oyo parent PRISM’s Rs 748 crore net profitOyo IPO: PRISM, formerly Oravel Stays, has reported a Rs 748 crore profit for the nine months ending December 31, 2025, a significant turna...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- Residential sales dip to lowest since Jan 2023 amid West Asia war, impacting buyer sentimentResidential sales in India experienced a significant dip in April-June, reaching the lowest point since early 2023. Geopolitical tensions a...
- Will Sensex, Nifty extend gains or turn volatile? Q1 updates, F&O expiry among 8 factors set to steer stock market this weekIndian markets head into a crucial week with investors tracking Q1 business updates, June F&O expiry, auto sales data, FII flows, crude oil...
- Q1 earnings preview: Here’s what Nomura expects from Nestle, Titan, other consumer majors’ June quarter resultsNomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
Load More
